![](/img/cover-not-exists.png)
A randomized phase III trial of gemcitabine+docetaxel+bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma (uLMS): A Gynecologic Oncology Group study
Hensley, M.L., Miller, A., O'Malley, D.M., Mannel, R.S., Behbakht, K., Bakkum-Gamez, J.N., Michael, H.Volume:
133
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2014.03.022
Date:
June, 2014
File:
PDF, 110 KB
english, 2014